Ashford Cancer Center

Ashford Cancer Centre Research (ACCR) is a premier private clinical research organization based in South Australia, specializing in oncology and haematology clinical trials. Founded by prominent oncologists including Associate Professor Dusan Kotasek and Dr. Francis Parnis, the center has established a global reputation for conducting high-quality Phase I, II, and III trials in collaboration with major pharmaceutical and biotechnology companies. In October 2020, ACCR was acquired by Icon Group, Australia's largest private cancer research provider, significantly expanding its capacity to deliver global clinical trials. The facility provides patients with access to cutting-edge therapies, including novel immunotherapies, targeted agents, and combination treatments. ACCR has been a key site for numerous landmark oncology studies, contributing to the development of several now-approved cancer drugs.